Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Pattern Group stock (PTRN) jumps 4.6% into year-end as traders hunt a floor

Pattern Group stock (PTRN) jumps 4.6% into year-end as traders hunt a floor

NEW YORK, December 30, 2025, 05:56 ET — Premarket Pattern Group Inc. shares climbed 4.6% in the prior session, closing at $12.38 and setting the stock up for a closely watched open in thin year-end trade. The move lifted the company’s market value to about $2.18 billion, based on Monday’s close. (https://stockanalysis.com/stocks/ptrn/history/) (https://stockanalysis.com/stocks/ptrn/market-cap/) That matters now because the final week of the year often brings lighter liquidity — fewer orders in the market — which can amplify price swings, especially in newer listings. Pattern has been choppy since it joined Nasdaq in September. The stock’s bounce also came against a
DigitalBridge stock jumps as SoftBank agrees $4 billion buyout at $16 a share

DigitalBridge stock jumps as SoftBank agrees $4 billion buyout at $16 a share

NEW YORK, December 30, 2025, 05:23 ET — Premarket DigitalBridge Group Inc (NYSE:DBRG) shares climbed 9.7% to $15.26 in premarket trading on Tuesday after SoftBank Group said it would buy the digital infrastructure investment manager in an all-cash deal. The acquisition lands as Wall Street’s focus on AI infrastructure shifts from chips to the physical plumbing behind them — data centers, fiber and power — areas where demand can rise quickly but capacity takes years and billions to build. “As AI transforms industries worldwide, we need more compute, connectivity, power, and scalable infrastructure,” SoftBank Chairman and CEO Masayoshi Son said.
Belite Bio stock swings to $170 and closes up nearly 7% as rally stays hot into year-end

Belite Bio stock swings to $170 and closes up nearly 7% as rally stays hot into year-end

NEW YORK, December 30, 2025, 05:26 ET — Premarket Belite Bio’s U.S.-listed shares were back in focus early Tuesday after the stock surged 6.7% in the prior session, swinging between $151.50 and $169.75 before ending at $165.29. Volume was 309,235 shares, above recent daily levels for the thinly traded biotech. StockAnalysis The move matters because Belite is trying to turn a rare-disease eye drug into a first-in-class launch, and the stock is now trading well above the $154 level at which it last sold new shares in a major December offering. In markets where liquidity thins out near year-end, sharp
USDA opens April 2026 Manila trade mission sign-ups as ube craze puts Philippines in focus

USDA opens April 2026 Manila trade mission sign-ups as ube craze puts Philippines in focus

NEW YORK, December 30, 2025, 04:42 ET The U.S. Department of Agriculture is accepting applications for its Agribusiness Trade Mission to Manila, scheduled for April 13-16, 2026, with a deadline of Friday, Jan. 9, the agency said. “U.S. agricultural exporters have an abundance of new opportunities in the Philippines, thanks to President Trump’s recent trade agreement,” said Luke J. Lindberg, USDA under secretary for trade and foreign agricultural affairs. USDA said the mission will align with the 80th anniversary of U.S.-Philippine diplomatic relations in 2026. https://www.fas.usda.gov/topics/trade-missions/philippines-april-2026 LinkedIn The application window comes as the Trump administration presses USDA to expand and
30 December 2025
Trenitalia’s €1 billion rail push: FS brings in Certares as Paris‑London battle heats up

Trenitalia’s €1 billion rail push: FS brings in Certares as Paris‑London battle heats up

NEW YORK, December 30, 2025, 04:45 ET Ferrovie dello Stato Italiane (FS) and U.S. investment firm Certares said they will create a joint venture and support a €1 billion investment plan to expand FS’s Paris-based Trenitalia France in France, Britain and other cross-border markets. (Source: https://www.fsitaliane.it/en/media/press-releases/2025/12/29/fs_group_certares_partnership_development_high_speed_international.html) The tie-up matters because it injects new capital and travel-distribution reach into Trenitalia’s push to break further into Europe’s busiest high-speed corridors, including the Paris–London route now served by Eurostar. It also comes as European passenger rail competition deepens under EU “rail liberalisation” rules — regulations that allow multiple operators to run passenger services
30 December 2025
Praxis Precision Medicines stock jumps after FDA Breakthrough Therapy tag for tremor drug, BTIG lifts target

Praxis Precision Medicines stock jumps after FDA Breakthrough Therapy tag for tremor drug, BTIG lifts target

NEW YORK, December 30, 2025, 05:21 ET — Premarket Praxis Precision Medicines Inc shares rose 13.25% on Monday to close at $304.58, after the U.S. Food and Drug Administration granted Breakthrough Therapy Designation for its essential tremor candidate ulixacaltamide, a filing showed. The stock opened at $317.72 and traded between $298 and $317.72, and was down about 1% in after-hours trading. StockAnalysis+2SEC+2 Breakthrough Therapy Designation is an FDA pathway meant to speed development and review for drugs aimed at serious conditions when early clinical evidence suggests a meaningful step up over available therapies. For traders, it often serves as a
Samsung and SK Hynix get U.S. 2026 license to ship chipmaking tools to China as key waiver expires

Samsung and SK Hynix get U.S. 2026 license to ship chipmaking tools to China as key waiver expires

NEW YORK, December 30, 2025, 04:40 ET The U.S. government has granted Samsung Electronics and SK Hynix annual licences to bring chip manufacturing equipment to their facilities in China for 2026, two people familiar with the matter said on Tuesday. Reuters The decision lands days before a broader privilege known as “validated end user” status expires on Dec. 31. The status allowed certain foreign-owned plants in China to receive some U.S.-origin chipmaking tools under sweeping exemptions rather than applying shipment by shipment. That timing matters for the memory-chip supply chain. Samsung and SK Hynix use China as a key production
NuScale Power (SMR) stock slips in premarket as SMR doubts weigh on nuclear names

NuScale Power (SMR) stock slips in premarket as SMR doubts weigh on nuclear names

NEW YORK, December 30, 2025, 04:49 ET — Premarket NuScale Power shares fell 2.4% to $14.48 in premarket trading on Tuesday, after ending the prior session at about $14.84. The move matters because “advanced nuclear” stocks have become a high-beta pocket of the market into year-end, swinging sharply on sentiment rather than earnings power. For investors, the debate has shifted from “who wins the SMR race” to “who can fund it without punishing shareholders.” Small modular reactors, or SMRs, are smaller nuclear units designed to be built largely in factories and deployed in modules. Backers pitch faster construction and easier
Micron stock today: MU jumps in premarket as memory-supply headlines keep traders on edge

Micron stock today: MU jumps in premarket as memory-supply headlines keep traders on edge

NEW YORK, December 30, 2025, 04:59 ET — Premarket Micron Technology shares were up 3.4% in premarket trading on Tuesday, indicating a move to about $294.37. The early rise comes as memory-chip stocks remain keyed to supply headlines. A Reuters report said the U.S. granted Samsung Electronics and SK Hynix annual licences for 2026 to bring chipmaking equipment into their China facilities, a development that could influence output at two major Micron rivals. Reuters Macro catalysts also loom large into year-end, when liquidity can be thin and price swings can look bigger than they are. The dollar held steady ahead
Palantir stock (PLTR) edges up in premarket as Fed minutes loom after tech pullback

Palantir stock (PLTR) edges up in premarket as Fed minutes loom after tech pullback

NEW YORK, December 30, 2025, 05:03 ET — Premarket Palantir Technologies Inc shares rose 0.4% to $184.90 in premarket trading on Tuesday, after ending the prior session at $184.18. Google The early move comes with investors focused on the Federal Reserve’s meeting minutes due at 2 p.m. ET, a release that often reshapes expectations for interest rates. Federal Reserve That matters for Palantir because fast-growing software stocks tend to be sensitive to changes in rate outlooks, which feed directly into how investors value future profits. Palantir fell 2.4% on Monday as U.S. stocks ended lower on a pullback in technology
Comcast stock ticks lower in premarket as Versant spinoff nears — what to watch next

Comcast stock ticks lower in premarket as Versant spinoff nears — what to watch next

NEW YORK, December 30, 2025, 04:53 ET — Premarket Comcast Corp shares were down 0.03% at $29.86 in premarket trading on Tuesday, after ending the prior session up 0.7%. Public The muted move comes as investors look past thin year-end trading and toward a near-term corporate reshaping: Comcast is days away from spinning off a portfolio of cable networks and digital assets into a separate company. Why it matters now is timing. The distribution date is close enough that trading mechanics — and how investors value the two companies on either side of the split — can drive short-term price
Apple stock today: AAPL steady in premarket as Barclays flags China iPhone rebound

Apple stock today: AAPL steady in premarket as Barclays flags China iPhone rebound

NEW YORK, December 30, 2025, 04:56 ET — Premarket Apple shares edged up 0.1% in premarket trading on Tuesday, changing hands around $273.76. The stock’s early move follows a fresh read-through on China demand, a key swing factor for Apple’s iPhone business and investor sentiment around the latest iPhone 17 cycle. The backdrop is cautious into year-end. U.S. stocks ended lower on Monday as heavyweight technology names retreated, and investors have Fed meeting minutes and weekly jobless claims on the radar in an otherwise data-light week. Reuters In a note citing China’s Ministry of Industry and Information Technology data based
1 480 481 482 483 484 884

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop